AND OBJECTIVES: Vestibular schwannomas (VS) are slow-growing tumors of the vestibular nerve. Gross total resection (GTR) is recommended for large tumors (> 4 cm), brainstem compression, cranial neuropathy, and hydrocephalus. In select complex cases at our high-volume skull base center, subtotal resection (STR) is pursued for various clinical factors....
Residual tumor volume after vestibular schwannoma surgery may serve as a useful metric for deciding who needs salvage radiotherapy, but the study's design and sample details are not yet fully available; await peer review details before adjusting post-surgical decision protocols.
Optimising the threshold for salvage radiotherapy in vestibular schwannoma could reduce unnecessary treatment exposure while preventing tumor regrowth, directly affecting surgical and neuro-oncology practice.
- 01Residual tumor volume post-surgery may predict need for salvage radiotherapy in vestibular schwannoma.
- 02Published in Journal of Neuro-Oncology (PMID 42105194; DOI 10.1007/s11060-026-05603-6).
- 03Findings could help stratify patients into observation vs. active radiation treatment pathways.
- 04Study focuses on post-surgical management rather than primary surgical technique.
- 05Evidence level and clinical applicability depend on study design details not fully disclosed in abstract.
Residual tumor volume after surgery guides post-operative treatment decisions in vestibular schwannoma.
studypartially supportedResidual tumor volume predicts the need for salvage radiotherapy following vestibular schwannoma resection.
studypartially supported- PMID
- 42105194
- DOI
- 10.1007/s11060-026-05603-6.
- Journal
- Journal of Neuro-Oncology
- Publication type
- research_article
- Evidence level
- 4
- Population
- Patients who underwent surgical resection of vestibular schwannoma with residual tumor volume post-operatively
- Intervention
- Post-surgical assessment of residual tumor volume to guide treatment decisions
Primary outcomes
Residual tumor volume as a predictor of salvage radiotherapy need; Post-surgical treatment pathway allocation